Voglibose-mediated alterations in neurometabolomic profiles in the hypothalamus of high-fat diet-fed mice

Soo Jin Yang, Hyun Ju Do, Youngae Jung, Geum Sook Hwang, Min-Jeong Shin

Research output: Contribution to journalArticle

Abstract

The alpha-glucosidase inhibitor voglibose (VO) was recently reported to have a protective effect against weight gain as well as affect various metabolic changes related to food intake and gut–brain signaling. We hypothesized that VO prevents weight gain by altering neurometabolome profiles in the hypothalamus to reduce food intake. To test this hypothesis, we assessed metabolite profiles in the hypothalamus of standard diet- or high-fat (HF) diet-fed mice in the absence or presence of VO. In total, 29 male C57BL/6 mice were divided into 3 groups: (1) lean control, (2) HF, and (3) HF + VO. Vehicle or VO was administered for 12 weeks. The results showed that there were alterations in levels of metabolites across several metabolic pathways in the hypothalamus. VO treatment increased levels of many amino acids including arginine, glutamine, histidine, isoleucine, leucine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine in the hypothalamus. In addition, levels of 2-hydroxy-2-methyl-butyric acid in the hypothalamus were significantly increased after VO administration in HF diet-fed mice. Among lipid metabolites, levels of fatty acids were higher in the hypothalamus of VO-treated mice than in that of HF diet-fed mice. In terms of the energy status, the ATP/ADP ratio was higher in the hypothalamus of VO-treated mice (P < 0.001), thereby indicating an energy surplus. In conclusion, VO supplementation altered metabolite profiles in the hypothalamus to enhance catabolism, which is possibly responsible for the hypophagic effect of VO in HF diet-fed mice.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalNutritional Neuroscience
DOIs
Publication statusAccepted/In press - 2018 Mar 3

Fingerprint

High Fat Diet
Hypothalamus
Weight Gain
voglibose
Eating
Fats
Butyric Acid
Isoleucine
Valine
Threonine
Metabolic Networks and Pathways
Glutamine
Phenylalanine
Inbred C57BL Mouse
Histidine
Proline
Leucine
Tryptophan
Methionine
Adenosine Diphosphate

Keywords

  • 2-Hydroxy-2-methyl-butyric acid
  • ATP/ADP ratio
  • Food intake
  • Hypothalamus
  • Metabolomics
  • Voglibose

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Neuroscience(all)
  • Nutrition and Dietetics

Cite this

Voglibose-mediated alterations in neurometabolomic profiles in the hypothalamus of high-fat diet-fed mice. / Yang, Soo Jin; Do, Hyun Ju; Jung, Youngae; Hwang, Geum Sook; Shin, Min-Jeong.

In: Nutritional Neuroscience, 03.03.2018, p. 1-8.

Research output: Contribution to journalArticle

@article{76baf6bac4d248c3b66d7a8459e4bf43,
title = "Voglibose-mediated alterations in neurometabolomic profiles in the hypothalamus of high-fat diet-fed mice",
abstract = "The alpha-glucosidase inhibitor voglibose (VO) was recently reported to have a protective effect against weight gain as well as affect various metabolic changes related to food intake and gut–brain signaling. We hypothesized that VO prevents weight gain by altering neurometabolome profiles in the hypothalamus to reduce food intake. To test this hypothesis, we assessed metabolite profiles in the hypothalamus of standard diet- or high-fat (HF) diet-fed mice in the absence or presence of VO. In total, 29 male C57BL/6 mice were divided into 3 groups: (1) lean control, (2) HF, and (3) HF + VO. Vehicle or VO was administered for 12 weeks. The results showed that there were alterations in levels of metabolites across several metabolic pathways in the hypothalamus. VO treatment increased levels of many amino acids including arginine, glutamine, histidine, isoleucine, leucine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine in the hypothalamus. In addition, levels of 2-hydroxy-2-methyl-butyric acid in the hypothalamus were significantly increased after VO administration in HF diet-fed mice. Among lipid metabolites, levels of fatty acids were higher in the hypothalamus of VO-treated mice than in that of HF diet-fed mice. In terms of the energy status, the ATP/ADP ratio was higher in the hypothalamus of VO-treated mice (P < 0.001), thereby indicating an energy surplus. In conclusion, VO supplementation altered metabolite profiles in the hypothalamus to enhance catabolism, which is possibly responsible for the hypophagic effect of VO in HF diet-fed mice.",
keywords = "2-Hydroxy-2-methyl-butyric acid, ATP/ADP ratio, Food intake, Hypothalamus, Metabolomics, Voglibose",
author = "Yang, {Soo Jin} and Do, {Hyun Ju} and Youngae Jung and Hwang, {Geum Sook} and Min-Jeong Shin",
year = "2018",
month = "3",
day = "3",
doi = "10.1080/1028415X.2018.1443995",
language = "English",
pages = "1--8",
journal = "Nutritional Neuroscience",
issn = "1028-415X",
publisher = "Maney Publishing",

}

TY - JOUR

T1 - Voglibose-mediated alterations in neurometabolomic profiles in the hypothalamus of high-fat diet-fed mice

AU - Yang, Soo Jin

AU - Do, Hyun Ju

AU - Jung, Youngae

AU - Hwang, Geum Sook

AU - Shin, Min-Jeong

PY - 2018/3/3

Y1 - 2018/3/3

N2 - The alpha-glucosidase inhibitor voglibose (VO) was recently reported to have a protective effect against weight gain as well as affect various metabolic changes related to food intake and gut–brain signaling. We hypothesized that VO prevents weight gain by altering neurometabolome profiles in the hypothalamus to reduce food intake. To test this hypothesis, we assessed metabolite profiles in the hypothalamus of standard diet- or high-fat (HF) diet-fed mice in the absence or presence of VO. In total, 29 male C57BL/6 mice were divided into 3 groups: (1) lean control, (2) HF, and (3) HF + VO. Vehicle or VO was administered for 12 weeks. The results showed that there were alterations in levels of metabolites across several metabolic pathways in the hypothalamus. VO treatment increased levels of many amino acids including arginine, glutamine, histidine, isoleucine, leucine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine in the hypothalamus. In addition, levels of 2-hydroxy-2-methyl-butyric acid in the hypothalamus were significantly increased after VO administration in HF diet-fed mice. Among lipid metabolites, levels of fatty acids were higher in the hypothalamus of VO-treated mice than in that of HF diet-fed mice. In terms of the energy status, the ATP/ADP ratio was higher in the hypothalamus of VO-treated mice (P < 0.001), thereby indicating an energy surplus. In conclusion, VO supplementation altered metabolite profiles in the hypothalamus to enhance catabolism, which is possibly responsible for the hypophagic effect of VO in HF diet-fed mice.

AB - The alpha-glucosidase inhibitor voglibose (VO) was recently reported to have a protective effect against weight gain as well as affect various metabolic changes related to food intake and gut–brain signaling. We hypothesized that VO prevents weight gain by altering neurometabolome profiles in the hypothalamus to reduce food intake. To test this hypothesis, we assessed metabolite profiles in the hypothalamus of standard diet- or high-fat (HF) diet-fed mice in the absence or presence of VO. In total, 29 male C57BL/6 mice were divided into 3 groups: (1) lean control, (2) HF, and (3) HF + VO. Vehicle or VO was administered for 12 weeks. The results showed that there were alterations in levels of metabolites across several metabolic pathways in the hypothalamus. VO treatment increased levels of many amino acids including arginine, glutamine, histidine, isoleucine, leucine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine in the hypothalamus. In addition, levels of 2-hydroxy-2-methyl-butyric acid in the hypothalamus were significantly increased after VO administration in HF diet-fed mice. Among lipid metabolites, levels of fatty acids were higher in the hypothalamus of VO-treated mice than in that of HF diet-fed mice. In terms of the energy status, the ATP/ADP ratio was higher in the hypothalamus of VO-treated mice (P < 0.001), thereby indicating an energy surplus. In conclusion, VO supplementation altered metabolite profiles in the hypothalamus to enhance catabolism, which is possibly responsible for the hypophagic effect of VO in HF diet-fed mice.

KW - 2-Hydroxy-2-methyl-butyric acid

KW - ATP/ADP ratio

KW - Food intake

KW - Hypothalamus

KW - Metabolomics

KW - Voglibose

UR - http://www.scopus.com/inward/record.url?scp=85042929856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042929856&partnerID=8YFLogxK

U2 - 10.1080/1028415X.2018.1443995

DO - 10.1080/1028415X.2018.1443995

M3 - Article

SP - 1

EP - 8

JO - Nutritional Neuroscience

JF - Nutritional Neuroscience

SN - 1028-415X

ER -